Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1077 to 1126 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent coatomer delta subunit (delta-coat protein) (delta-cop) (archain). [source:swissprot;acc:p48444]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 174.387\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 179.697\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03045\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent coatomer zeta-2 subunit (zeta-2 coat protein) (zeta-2 cop). [source:swissprot;acc:q9p299]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 444; endothelial zinc finger protein 2. [source:refseq;acc:nm\_018337]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 269.896\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 278.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03037\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 223.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.03027\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 220.118\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.685\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.03011\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 231.007\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 237.864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02968\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to zinc finger protein 277. [source:sptrembl;acc:q8wwa6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 236.679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 243.679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02958\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 277. [source:swissprot;acc:q9nrm2]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.673\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.378\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0295\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 121.428\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 125.004\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02945\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.218\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 232.88\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.205\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 232.858\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02941\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s acidic ribosomal protein p0 (l10e). [source:swissprot;acc:p05388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.203\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 232.855\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 177.432\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 182.647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02939\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.655\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.385\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02938\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 213.552\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.463\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02935\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.345\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 206.339\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02911\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 203.208\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 3 mu 1 subunit (mu-adaptin 3a) (ap-3 adapter complex mu3a subunit). [source:swissprot;acc:q9y2t2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.323\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02906\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 3 mu 2 subunit (clathrin coat assembly protein ap47 homolog 2) (clathrin coat associated protein ap47 homolog 2) (golgi adaptor ap-1 47 kda protein homolog 2) (ha1 47 kda subunit homolog 2) (clathrin assembly protein assembly protein complex 1 medium chain homolog 2) (p47b). [source:swissprot;acc:p53677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.315\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02904\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.052\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 203.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02889\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 220.291\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.584\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02857\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 229.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.974\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02847\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 229.441\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 235.972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02846\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyacid oxidase 1 (ec 1.1.3.15) (haox1) (glycolate oxidase) (gox). [source:swissprot;acc:q9ujm8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 231.922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 238.486\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0283\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 191.139\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 185.882\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02828\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 212.945\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02818\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine palmitoyltransferase 2 (ec 2.3.1.50) (long chain base biosynthesis protein 2) (lcb 2) (serine-palmitoyl-coa transferase 2) (spt 2). [source:swissprot;acc:o15270]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 204.603\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.324\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02796\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.006\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.119\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02775\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.209\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02769\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.123\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02766\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 251.863\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 258.829\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth arrest and dna-damage-inducible protein gadd45 gamma (cytokine responsive protein cr6). [source:swissprot;acc:o95257]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth arrest and dna-damage-inducible protein gadd45 alpha (dna- damage inducible transcript 1) (ddit1). [source:swissprot;acc:p24522]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hepatocyte nuclear factor 4-alpha (hnf-4-alpha) (transcription factor hnf-4) (transcription factor 14). [source:swissprot;acc:p41235]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth arrest and dna-damage-inducible protein gadd45 beta (negative growth-regulatory protein myd118) (myeloid differentiation primary response protein myd118). [source:swissprot;acc:o75293]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 168.989\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 164.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02754\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 168.995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 164.467\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02753\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 218.528\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.676\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02752\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 1121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.529\vspace{3pt}}&&\\\cline{1-3}\cline{5-5} \parbox{\wcA}{\vspace{3pt}\noindent 1122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.527\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent 1.02751\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 169.031\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 164.507\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0275\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peroxiredoxin 5, mitochondrial precursor (prx-v) (peroxisomal antioxidant enzyme) (plp) (thioredoxin peroxidase pmp20) (antioxidant enzyme b166) (aoeb166) (tpx type vi) (liver tissue 2d-page spot 71b) (alu co-repressor 1) (sbbi10). [source:swissprot;acc:p30044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.553\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.256\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.02748\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj718p11.1.2 (novel class ii aminotransferase similar to serine palmotyltransferase (isoform 2)) (fragment). [source:sptrembl;acc:q9ugb5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 204.404\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.022\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.487\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.02742\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/